MedTrace Logo

Barbershop Talk: HIV Prevention for African American Heterosexual Men

NCT01980771 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 860

Last updated 2021-10-27

Study results available
· View outcomes & findings →

Summary

This program utilizes a community-engaged research approach to implementing and evaluating a program that seeks to reduce sexual risk behavior among Black adult heterosexual men. The investigators aims are to assess the impact of this linguistically and culturally tailored HIV prevention program on the sexual risk of heterosexual, African American men aged 18 and older, to assess the intervention's impact on the more proximal social and psychosocial variables that the program is designed to change, and to identify key contextual level factors that may impact the intervention's impact across segments of this priority population.

Conditions

Interventions

BEHAVIORAL

BTWB intervention

Men work in groups to complete a intervention that takes approximately two hours to complete.

BEHAVIORAL

Cancer prevention and screening

Men are provided health education about cancer screening and prevention

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • State University of New York - Downstate Medical Center

    lead OTHER

Principal Investigators

  • Tracey E Wilson, PhD · State University of New York - Downstate Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2017-02-28
Completion
2017-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01980771 on ClinicalTrials.gov